This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Isis Pharmaceuticals, Inc.. Active years: 2001-2010.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2010
Title: Scott W. Henry: Innovator in HIF1-beta Modulation
Introduction
Scott W. Henry is a notable inventor based in Cardiff, CA (US). He has made significant contributions to the field of biotechnology, particularly in the modulation of HIF1-beta expression. With a total of 3 patents to his name, his work has implications for the diagnosis and treatment of various diseases.
Latest Patents
Henry's latest patents focus on the modulation of HIF1-beta expression. The compounds, compositions, and methods he has developed provide innovative approaches for modulating the expression of HIF1-beta. These compositions comprise oligonucleotides targeted to nucleic acid encoding HIF1-beta. His methods are designed for the diagnosis and treatment of diseases and conditions associated with the expression of HIF1-beta.
Career Highlights
Scott W. Henry is currently associated with Isis Pharmaceuticals, Inc. His work at the company has been instrumental in advancing research in the field of gene expression modulation. His innovative approaches have garnered attention in the scientific community.
Collaborations
Henry has collaborated with notable colleagues, including Eric G. Marcusson and Youngsoo Kim. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Scott W. Henry's contributions to the modulation of HIF1-beta expression highlight his role as a leading inventor in biotechnology. His work continues to pave the way for advancements in medical treatments and diagnostics.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile